Bliss GVS Pharma financial results announcements

Bliss GVS Pharma Q2 FY27 Results: Net Profit ₹53.3 Cr, Up 86.4% YoY

Bliss GVS Pharma Ltd reported revenue from operations of ₹313.4 Cr (+28.2% YoY) and net profit of ₹53.3 Cr (+86.4% YoY) for Q2 FY27.

Key figure

Net profit ₹53.3 Cr · +86.4% YoY

Bliss GVS Pharma Q1 FY27 Results: Net Profit ₹51.4 Cr, Up 15.8% YoY

Bliss GVS Pharma Ltd reported revenue from operations of ₹285.6 Cr (+37.6% YoY) and net profit of ₹51.4 Cr (+15.8% YoY) for Q1 FY27.

Key figure

Net profit ₹51.4 Cr · +15.8% YoY

Bliss GVS Pharma Q4 FY26 Results: Net Profit ₹37 Cr, Up 121.6% YoY

Bliss GVS Pharma Ltd reported revenue from operations of ₹257 Cr (+29.8% YoY) and net profit of ₹37 Cr (+121.6% YoY) for Q4 FY26.

Key figure

Net profit ₹37 Cr · +121.6% YoY

Bliss GVS Pharma Financial Results

Bliss GVS Pharma reported audited standalone and consolidated financial results for the year ended March 31, 2026. The Board also recommended a 100% final dividend.